# Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome

> **NCT05867693** · NA · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 70 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** palmithoylethanolamide/polydatin
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT05867693
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-19
- **Primary completion:** 2023-10-19
- **Final completion:** 2024-04-19
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05867693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05867693, "Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05867693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*